Literature DB >> 17450342

[Treatment of a leg ulcer with bosentan in a female patient with progressive systemic scleroderma].

I Rösener1, A Rübben.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17450342     DOI： 10.1007/s00105-007-1336-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  5 in total

1.  Bosentan in pulmonary arterial hypertension secondary to scleroderma.

Authors:  Amit Joglekar; Fausan S Tsai; Deborah A McCloskey; Julianne E Wilson; James R Seibold; David J Riley
Journal:  J Rheumatol       Date:  2006-01       Impact factor: 4.666

2.  Successful treatment of systemic sclerosis-related digital ulcers and sarcoidosis with endothelin receptor antagonist (bosentan) therapy.

Authors:  J Tillon; F Hervé; D Chevallier; J-F Muir; H Levesque; I Marie
Journal:  Br J Dermatol       Date:  2006-05       Impact factor: 9.302

3.  Bosentan as a rescue therapy in scleroderma refractory digital ulcers.

Authors:  Melanie Chamaillard; Isabelle Heliot-Hosten; Joël Constans; Alain Taïeb
Journal:  Arch Dermatol       Date:  2007-01

4.  Digital ulcers in systemic sclerosis: prevention by treatment with bosentan, an oral endothelin receptor antagonist.

Authors:  J H Korn; M Mayes; M Matucci Cerinic; M Rainisio; J Pope; E Hachulla; E Rich; P Carpentier; J Molitor; J R Seibold; V Hsu; L Guillevin; S Chatterjee; H H Peter; J Coppock; A Herrick; P A Merkel; R Simms; C P Denton; D Furst; N Nguyen; M Gaitonde; Carol Black
Journal:  Arthritis Rheum       Date:  2004-12

Review 5.  Bosentan for the treatment of systemic sclerosis-associated pulmonary arterial hypertension, pulmonary fibrosis and digital ulcers.

Authors:  Manu Jain; John Varga
Journal:  Expert Opin Pharmacother       Date:  2006-08       Impact factor: 3.889
  5 in total
  1 in total

1.  Successful treatment with bosentan of lower extremity ulcers in a scleroderma patient.

Authors:  Alix Naert; Petra De Haes
Journal:  Case Rep Med       Date:  2013-04-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.